Introduction
The calcium/calmodulin-dependent protein kinase IV (CaMKIV) is a downstream protein of Ca 2+ signaling cascades. To be active, CaMKIV requires binding of Ca 2+ /CaM [1] . The expression of CaMKIV has been demonstrated predominately in cells of immune systems [2] [3] [4] . It has reported that CaMKIV inhibition/silence leads to the suppression of IFN-γ production in T cells and B cells [5] , as well, of antibody production, and of expression of CD80 and CD86 on B cells [3, 5, 6] . In addition, the expression of CaMKIV is developmentally regulated in monocyte-derived dendritic cells (DCs). Knocking off CaMKIV makes DCs expressing MHC class II fail to accumulate [4] . These reports suggest CaMKIV is essential for lymphocyte activation, proliferation and functions.
Skeletal muscle cells do not express detectable levels of major histocompatibility complex (MHC) molecules in physiological conditions while they had been demonstrated previously to be capable of expressing both MHC-I and MHC-II upon chronic inflammation condition (such as polymyositis) [7] [8] [9] . In vitro, human myoblasts and myotubes express MHC molecules (HLA-DR), either constitutively or after treatment with IFN-g [10, 11] . Muscle cells can also be induced to express the toll-like receptors (TLRs), some B7-related co-stimulatory/regulatory molecules, and adhesion molecules (e.g., intercellular adhesion molecule 1) [12] [13] [14] . This suggests that, under pro-inflammatory environment, skeletal muscle cells are capable of expressing immunological molecules and actively participate in muscle immune/inflammatory reactions. Whether CaMKIV signal effects on the intrinsic immunological capacities of muscle cells, like it does for immune cells, remains mostly unknown.
Reports for CaMKIV expression and function in muscle tissue are conflict. Several studies previously implicate CaMKIV in the Ca 2+ -dependent regulation of muscle gene expression, specifically in the activation of mitochondrial biogenesis and oxidative enzyme expression [1, [15] [16] [17] . However, other studies show a lack of CaMKIV expression in skeletal muscle, and CaMKIV is indicated not required for the maintenance of slow-twitch muscle phenotype and endurance training-induced mitochondrial biogenesis in murine skeletal muscle [18] . In our previous work, the striking up-regulation of CaMKIV protein level was observed in regenerated myofibers in Cardiotoxin (CTX)-damaged the tibialis anterior (TA) muscle, while, CaMKIV knockdown reverses IFN-g induced up-regulation of MHC class-I/II and TLR3 in myocytes [19] , indicating CaMKIV can be induced to express or up-regulate in muscle cells under pro-inflammatory stimuli, and it may have a role on regulating the immune behaviors of myocytes. In this study, we extend our investigations on immune characteristics and CaMKIV expression in C 2 C 12 cells and in murine myogenic precursor cells (MPCs), and demonstrated that, IFN-γ induces the expression or up-regulation of the immuno-related molecules, and of CaMKIV in muscle cells. In striking contrast, CaMKIV knockdown in C 2 C 12 cells leads to the expression inhibition of MHC class I/II, some pro-inflammatory cytokines/ chemokines, and co-stimulatory molecules. Finally, we found CaMKIV knockdown abolishesSanta Cruz Biotechnology, Inc.] which were designed to suppress the production of CaMKIV in mouse cells. C 2 C 12 cells that were transfected with shRNA lentiviral particles with noneffective scrambled shRNA sequences control (shRNA-control) [shRNA lentiviral particles-A (sc-108080), Santa Cruz Biotechnology, Inc.] were used as the control. Infections were performed following the manufacture's instructions. For the establishment of stable clones, 3 μg/ml puromycin (Santa Cruz Biotechnology, Inc.) was added into culture medium for selection and maintenance of cell lines expressing a transfected pac gene. Fresh puromycincontaining medium was replaced every 3-4 days until resistant colonies can be identified. Cell clones with stable CaMKIV knockdown were further cultured with complete medium including 1 μg/ml puromycin, or were induced into differentiated myotubes in the DMEM/F12 media containing 2% horse serum and 1 μg/ ml puromycin for 72 h. For recovering intracellular CaMKIV production in CaMKIV knockdown cells, double stranded improved DNA (http://www.jcat.de/) specific to mouse CaMKIV was synthesized (Sangon Biotech Co., China) and was inserted into the vector of pEGFP-N1 (Clontech) via XhoI and EcoRI sites screened for efficient recover CaMKIV (pEGFP-N1-CaMKIV). pEGFP-N1-CaMKIV plasmid transfection was performed using Lipofectamine 2000™ (Invitrogen): CaMKIV knockdown C 2 C 12 cells were cultured in 24 well plates, transfected with 8 μg pEGFP-N1-CaMKIV plasmid. To obtain cells stably re-expressing CaMKIV, the cells were screened with 10% minimum essential medium containing 400 ng/ml G418 (Gibco). After that, the cells were fixed in 4% paraformaldehyde, incubated with DAPI to label the nuclei and examined under the fluorescence microscopy (fluorescence microscopy Olympus BX53, Japan). The CaMKIV recovered (reCaMKIV) cells were induced into differentiated myotubes in DMEM/F12 media containing 2% horse serum for 72 h. Effectiveness of the pEGFP-N1-CaMKIV plasmid transfection was verified by PCR and Western blots analysis. For blocking CREB activity in muscle cells, 250 μM KG-501 (Sigma-Aldrich Co. LLC.) [21] were added into cell culturing system. For pro-inflammatory stimulation, myoblasts or myotubes transfected or not were treated with IFN-γ (60 ng/ml, R&D, USA) [22] .
RNA extraction and quantitative real-time PCR analysis
Total RNA from MPCs or C 2 C 12 cells was extracted using Trizol reagent (Invitrogen, USA), according to instructions provided by the manufacturer. 1 ug RNA was then used for reverse transcription (RT) with commercially available kit (Revert Aid First Strand cDNA Synthesis Kit, Fermentas; PrimeScript TM RT reagent Kit With gDNA Eraser, TaKaRa). Real-time polymerase chain reaction (PCR) was performed in triplicate with an ABI Step One Plus system (Applied Biosystems, USA) and a fluorescence-labeled SYBR Green/ROX qPCR Master Mix kit (Fermentas) using specific primers. CaMKIV, IL-1β, TNF-α, IL-6, MCP-1, MIP1a, CREB1, MEF-2a, MEF-2b, MEF-2d, Bcl-xl, STAT1, IRF1, JAK1 and with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) taken as an endogenous control (primer sequences are listed in Table 1 ), were detected. To provide quantification, the point of product accumulation in the early logarithmic phase of the amplification plot was defined by assigning a fluorescence threshold above the background, defined as the threshold cycle (Ct) number. Relative expression of different gene transcripts was calculated by the ΔΔCt method. The Ct of any gene of interest was normalized to the Ct of GAPDH. Fold changes (arbitrary units) were determined as 2 −ΔΔCt [23] . Flow cytometric analysis C 2 C 12 myoblasts and myotubes received different treatments were digested by 0.25% trypsin with 0.04% EDTA (Gibco, USA), and centrifuged at 1000 rpm for 3 min. After washing twice by ice-cold PBS, single cell suspensions (1×10 6 cells/sample in 100 μl of PBS) were stained with following antibodies for 30 min at 25-30°C separately: phycoerythrin (PE)-conjugated anti-mouse CD40, allophycocyanin (APC)-conjugated anti-mouse PD-L1, fluorescein isothiocyanate (FITC)-conjugated anti-mouse CD86, or FITCconjugated anti-mouse ICAM-1 (all from Biolegend, USA). Cells were washed twice with 1 ml PBS again and then resuspended in 200 μl PBS before analyzed on a FACS AriaII flow cytofluorometer (BD Biosciences) using FlowJo7.6.1 software. Samples were gated on live cells and 10 5 live cell events per sample were collected.
Immunofluorescence detection
For immunofluorescent labeling, cells were firstly plated on microscope cover glass (Nest, China), and then fixed in cold acetone for 10 min, permeabilized with 0.1% Triton X-100 for 10 min before washed twice in PBS and incubated with Rabbit polyclonal MyoD ( 
Statistical Analysis
All data are expressed as mean ± standard deviation (SD). One-way ANOVA was used for multiple comparisons (Duncan's multiple range test) using SPSS ver.13.0 software. P values<0.05 were considered as statistically significant.
Results

IFN-γ induces the expression or up-regulation of immuno-molecules and CaMKIV in myoblasts and myotubes from C 2 C 12 and murine myogenic precursor cells
Under physiological conditions, MHC class I and II is virtually undetectable in muscle. However, MHC expression is strongly up-regulated on the muscle fiber in inflammatory Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry muscle diseases, such as polymyositis (PM) [7] [8] [9] . Muscle fibers are therefore believed to be the primary target of the immune attack in inflammatory myopathies. Since we already reported immuno-molecules expression in C 2 C 12 myoblasts and myotubes, involving MHC-I molecule H-2K b , MHC-II molecule H2-Ea and TLR3 [19] , here we further evaluated the above molecules expression in murine myogenic precursor cells (MPCs). C 2 C 12 cells, or MPCs were cultured in IFN-g-constructed inflammatory environment, added with or without 2% horse serum. In agreement with the analysis results of C 2 C 12 cells, we observed MPCs survived well and can be successfully differentiated to form multinucleated myotubes under horse serum administration (Fig. 1A) . In myoblasts, H-2K b and TLR3 continuously low-expressed, and their protein levels significantly up-regulated by 72 h-IFN-g treatment. Differentiated myotubes expressed H-2K b and TLR3 more highly than myoblasts after inflammatory stimuli. H2-Ea was only detected in myotubes, and the level was significantly increased in the presence of IFN-g (Fig. 1B) .
CaMKIV protein is reported to be undetectable in skeletal muscle in some previous studies, and thus CaMKIV is believed to be not required for functioning as endogenous mediators of activity-dependent changes in myofiber phenotype [18] . Recently we found regenerated new myofibers in CTX-damaged muscle highly expressed CaMKIV [19] , hence, it is possible that CaMKIV expression is inducible in myocytes under inflammatory environment. To definitively establish this point, in this study, we investigated CaMKIV protein levels in C 2 C 12 cells and MPCs by immunoblot analysis and evidenced the results by the extra CaMKIV antibody competition test. As expected, CaMKIV mRNA level was rather low in myoblasts and differentiated myotubes, but significantly up-regulated in muscle cells after 72 h-IFN-γ stimuli ( Fig. 2A) , which implies that, although absent under normal culture conditions, CaMKIV is inducible in the presence of IFN-γ. Consistent with the previous reports [18] , our protein analysis demonstrated that, 3 bands closed with each other, can be recognized in myoblasts and myotubes. Among them, 2 bands were not affected by CaMKIV antibody competition, but very interestingly, the first band, which can be observed in IFN-γ treated myoblasts and myotubes, disappeared after antibody competition, as that happened in brain tissue after antibody competition (Fig. 2B, C) . Hence, we believe CaMKIV protein can be induced to express or up-regulate in muscle cells after pro-inflammatory stimuli, which is further evidenced by a marked increase of p-CaMKIV protein level in IFN-γ treated myoblasts and myotubes (Fig. 2B, C) , and by an immunofluorescence staining results (Fig. 2D) .
shRNA transfection inhibits CaMKIV expression in C 2 C 12 cells under the IFN-g induced proinflammatory milieu
Using CaMKIV-shRNA lentivirus knockdown skill, we already obtained C 2 C 12 cell clones with CaMKIV gene silence [19] . To definitively confirming knockout efficiency of CaMKIV 
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Cellular Physiology and Biochemistry in shRNA-CaMKIV transfected myoblasts and myotubes (Fig. 3A) . In addition, CaMKIV protein absence in the transfected cells was further confirmed by our immunofluorescence detection results (Fig. 3B) .
CaMKIV inhibition reverses IFN-g induced up-regulation of pro-inflammatory cytokines/ chemokines in C 2 C 12 myoblasts and myotubes
Human myoblasts and differentiated myotubes have been demonstrated to up-regulate HLA-I (MHC-I) and TLR3, or express HLA-II antigen HLA-DR under the treatment with IFN-γ in vitro [10, 12] . Our recent immunobloting analysis supported this point, and we further found endogenous CaMKIV signal interferes with immunological capacities of muscle cells [19] . Here, we re-validated the effects of CaMKIV on immune-molecules expression in muscle cells received CaMKIV-shRNA or the control sc shRNA treatment, through immunofluorescence staining. Consistently, we observed that, under IFN-g-constructed proinflammatory condition, CaMKIV knockdown reversed IFN-g induced up-regulation of H-2K b and TLR3 in myoblasts and myotubes, and of H2-Ea in myotubes (Fig. 4A) .
The secretion of soluble mediators, such as IL-1, IL-6, IL-15, MCP-1, TGF-β, and TNF-α has been described in muscle cells of inflammatory myopathies [24, 25] , or in cultured myoblasts received IFN-g, IL-1α, IL-1β, TNF-α or LPS stimulation [26] . Using qRT-PCR analysis, we demonstrated that, sc shRNA transfected C 2 C 12 myoblasts and myotubes constitutively expressed low levels of IL-1β, IL-6, TNF-α, MIP-1α and MCP-1. After IFN-g stimulation, myoblasts and myotubes up-regulated IL-1β, IL-6 and MIP-1α expression. However, TNF-α and MCP-1 were observed to increased gene levels only in horse serum-differentiated myotubes, but not in myoblasts (Fig. 4B ). Of note, CaMKIV knockdown decreased IL-6 level in IFN-g treated myoblasts. Interestingly, in CaMKIV gene deficient myotubes received IFN-g administration, mRNA levels of IL-1β, IL-6, TNF-α, MIP-1α and MCP-1 markedly downregulated, comparing to the sc shRNA treated control cells (Fig. 4B) , suggesting CaMKIV signal selectively suppresses the production of cytokines and chemokines in IFN-g treated muscle cells, and this inhibition mainly occurred in differentiated myotubes.
CaMKIV knockdown selectively inhibits co-stimulatory molecules expression in IFN-g treated myoblasts and myotubes
Co-stimulation signals are crucial to the activation of lymphocytes and development of immune response. Muscle cells have been considered as the facultative antigen-presenting cells (APCs) that maintain a muscle-directed immune response, and some co-stimulatory molecules, including CD40, inducible costimulator-ligand (ICOS-L), programmed deathligand 1 (PD-L1) and intercellular adhesion molecule (ICAM-1), had been identified in muscle fibres of myositis [10, 27, 28] , and were inducible in human myoblasts in vitro [14] . 
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To evaluate whether CaMKIV signal interferes with the co-stimulatory signal molecules expression in muscle cells, we turned to FACS analysis for CaMKIV knocked-myoblasts or -myotubes under IFN-g stimulation. As expected, a higher proportion of CD40, CD86, PD-L1 or ICAM-1 positive myoblasts and myotubes were found in sc shRNA treated control cells received IFN-g treating, as compared to cells with no IFN-g treating (Fig. 5) . In contrast, CaMKIV knockdown inhibited IFN-g induced expression of CD40, CD86 and ICAM-1 in muscle cells, because the positive cell number significantly decreased (Fig. 5) . Interestingly, we found CaMKIV knockdown had little effect on the percentage of PD-L1 positive cells in the presence of IFN-g (Fig. 5) . Since PD-L1 has been reported to exert strong immuno-inhibitory function, this result would be in agreement with the finding that endogenous CaMKIV works as a positive regulator for immune cell functions [29] .
CaMKIV knockdown abolishes IFN-g induced CREB pathway molecules accumulation in differentiated myotubes
In immune cells (e.g., macrophage), IFN-g-induced cellular responses are mediated mainly through Jak-Stat activation [30] . In addition, cAMP response element-binding protein 
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(CREB) is thought as the co-regulator of the IFN-g signaling pathway. Noteworthy, the key effects of CaMKIV in cells of the immune system involve modulation of the activity of CREB, its co-activator CBP and the myocyte enhancer factor-2 (MEF-2) [31] . In order to address IFN-g activated downstream signaling in muscle cells, and to further determine whether CaMKIV mediates the IFN-g activation signaling in muscle cells, we investigated gene levels of the key molecules of Jak-Stat and CREB signal pathways in IFN-g-treated myoblasts and myotubes knocked down CaMKIV or not. Our qRT-PCR data verified that, in the sc shRNA transfected control C 2 C 12 cells, especially in myotubes (72 h differentiation), IFN-g induced a significant mRNA level increase of CREB pathway molecule CREB1, Bcl-xl and MEF-2 (a, b and d), and of Jak-Stat pathway molecule Stat1, IRF-1 and JAK1 (Fig. 6A, B) . In striking contrast, in CaMKIV knocked myotubes, but not myoblasts, IFN-g failed to induce up-regulation of gene levels of CREB1, Bcl-xl and MEF-2. Instead, Stat1, IRF-1 and JAK1 levels are not affected by CaMKIV knockdown (Fig. 6A, B) . Hence, it is possible that CaMKIV mediates IFN-g-activated CREB signal pathway in muscle cells. To definitively establish this point, we further explored CREB1 activation in CaMKIV knocked cells. As a result, we observed the significant down-regulation for p-CREB1 protein level in IFN-g-treated myotubes after CaMKIV knockdown, as compared to that of IFN-g-treated control cells (received sc shRNA transfection) (Fig. 6C ). Since IFN-g and lentivirus transduction may induce numerous genes activation, and the up-regulation of CREB pathway molecules in muscle cells may not necessarily mediated by CaMKIV, we next assessed the CaMKIV effects on CREB pathway molecules in muscle cells after CREB signal blockade in vitro. In the IFN-g-induced pro-inflammatory condition, when we added CREB1 antagonist KG-501 into the culturing system of the sc shRNA transfected control cells, we detected markedly decrease of CREB1, Bcl-xl and MEF-2 gene levels, as comparing to cells with no KG-501 treating (Fig. 6D) , suggesting that IFN-g induced up-regulation of CREB pathway molecule levels in muscle cells is not affected by lentivirus treatment. When we performed CaMKIV recover transfection (reCaMKIV) to correct intracellular CaMKIV level of knocked cells (Fig. 6E, F) , we found CREB1, Bcl-xl and MEF-2 gene level significantly increased, compared to the knocked cells (Fig. 6G) . However, when we further added KG-501 into this cell system, CREB1, Bcl-xl and MEF-2 gene level decreased again (Fig. 6H) . It, therefore, appears that CaMKIV mediates IFN-g-activated CREB signal pathway in muscle cells.
Discussion
CaMKIV is a multifunctional Ser/Thr kinase encoded by the CaMKIV gene, which requires Ca 2+ /CaM for its activity [31] . This enzyme is considered as a necessary element for function of calcium in immune, and regulates various cellular events through phosphorylation of transcription factors which play pivotal roles in immune response and inflammation [31, 32] . During skeletal muscle pathologic state (e.g., myositis), muscle cells can express a variety of immunologically important molecules, and can actively participate in local immune reactions [33, 34] . Recently, using CTX induced mice myoinjury model, we found the regenerated myofibers up-regulate CaMKIV level in inflammatory condition, and CaMKIV can act as an immunostimulation molecule to enhance the acute muscle inflammatory responses [19] . In this work, we further show the importance of endogenous CaMKIV in impacting on the intrinsic immunological properties of muscle cells under pro-inflammatory condition.
CaMKIV is differentially expressed in adult thymocyte subsets, and affects T cell development. Studies in CaMKIV _/_ mice confirmed the enzyme signal contributes to subsets selection, survival, activation, proliferation and function of T cell [35] . In addition, CaMKIV is reported to prompt the viability and proliferation of monocyte-derived dendritic cells exposed to bacterial lipopolysaccharides [4] . From the previous reports, CaMKIV protein is not detectable in murine and human skeletal muscle, and therefore CaMKIV is considered to be not required for the maintenance of muscle fiber phenotype and basal level mitochondrial biogenesis [18] . In agreement, we also noticed the absence of CaMKIV gene and protein Recent work has shown that CaMKIV regulates terminal differentiation and survival of APCs. Genetic ablation of CaMKIV in monocyte-derived dendritic cells leads to a marked defect in typical markers of mature myeloid DC in response to LPS, involving MHC-II molecule I-A and TLR4 [15] . Skeletal muscle cells have been proposed to be the facultative APCs. Cultured human myoblasts express constitutively the classical human leukocyte (HLA) class I antigens, TLR3 and TLR7, and the expression level is increased by proinflammatory cytokines (e.g. IFN-γ, TNF-α, IL-1α, et al.) [10, 12] , which hints muscle cells can actively participate in local immune reactions. In line with this, we observed the obvious expression up-regulation of H-2K b (MHC-I), TLR3 and H2-Ea (MHC-II) in myoblasts and myotubes in the presence of proinflammatory IFN-g. Recently, we found the up-regulation of active CaMKIV protein in Cardiotoxin-damaged TA muscle in B6 mice [19] , which raises an important question, whether CaMKIV signaling only acts on intramuscular infiltrated lymphocytes, or interferes with immunological capacities of muscle cells simultaneously? In this study, we provide evidence for a positive regulation role of CaMKIV in the immune behaviors of muscle cells. Our present data shown that, CaMKIV gene knockdown can reverse IFN-g-induced upregulation of MHC-I/II and TLR3 in C 2 C 12 myoblasts and myotubes. As well, some inducible co-stimulatory molecules, involving CD40, CD86 and ICAM-1, were significantly suppressed by CaMKIV knockdown in myoblasts and myotubes. Of note, we detected CaMKIV knockdown has no effect on PD-L1 expression in IFN-g induced C 2 C 12 cells. Since PD-L1 exerts immunoinhibitory function [29] , this finding further support CaMKIV is a positive intervention factor for muscle immune behaviors.
Muscle cells are capable of secreting soluble mediators as well as immunocompetent cells invading the muscle tissue during the inflammation stage [36] . Alternatively, human myoblasts can be induced to produce IL-6, IL-1α, IL-1β and TNF-α in vitro [37] [38] [39] . Consistently, we also found, in IFN-g constructed inflammatory milieu, myoblasts and myotubes upregulated mRNA levels of IL-1β, IL-6 and MIP-1α, and additionally, myotubes up-regulated TNF-α and MCP-1 levels. CaMKIV has been proposed to control the activity of cytokines in APCs, T cell and B cells. Macrophage from CaMKIV _/_ mice reduced IL-6 production [40] . As well, CaMKIV _/_ mice sourced CD4 memory T cells are markedly defect in the synthesis of IL-2, IL-4 and IFN-g, because of their inability to phosphorylate CREB in response to TCR stimulation [41] . In B cells from MRL/lpr mice, CaMKIV antagonist KN-93 was able to block LPS-induced production of IFN-γ and to significantly reduce the secretion of TNF-α [5] . Our results show that, knockdown of CaMKIV attenuates IFN-g induced up-regulation of IL-1β, IL-6, TNF-α, MIP-1α and MCP-1 in myotubes. This data further support the involvement of CaMKIV signal in interfering with crucial immune phenotype of muscle cells in vitro.
IFN-γ is a macrophage-activating cytokine that serves critical functions in innate and adaptive immunity and is thought to be mediated by the Jak-Stat signaling pathway [30] . Besides, IFN-g has been suggested to mediate immune cell response through regulating cAMP/ PKA/CREB signal [42] . Exposure of muscle cells to IFN-γ can up-regulate immunological important molecules, including MHC and co-stimulatory molecules, thus induces muscle cells to be the facultative APCs [43, 44] . We demonstrated herein that, in IFN-γ provoked myoblasts and myotubes, both of CREB and Jak-Stat pathway molecules significant increased. Noteworthy, CaMKIV inhibition alternatively abolishes IFN-g induced up-regulation of CREB pathway molecules, as well, CaMKIV inhibition reverses the IFN-γ induced CREB1 activation in myotubes. Moreover, CaMKIV recover transfection makes the re-increase of CREB1, Bcl-xl and MEF-2 level in knocked cells. In macrophages and DCs, CaMKIV functions as a physiological inducer of CREB activation in response to increased intracellular Ca is involved in the regulation of differentiation and survival of monocyte-derived immune cells [31] . From the present data, it is possible that CaMKIV mediates IFN-g-activated CREB signal pathway in muscle cells. Although C 2 C 12 myoblasts and myotubes represent the most widely accepted in vitro system to investigate and characterize the biological properties of skeletal muscle cells, it should be noted that the usage of CaMKIV knocked C 2 C 12 cells instead of primary MPC cells is still a limitation for determining the role of CaMKIV on regulating intrinsic immunologic features of muscle cells, and we believe the detailed mechanisms leading CaMKIV to impact immune capacities of muscle cells can be revealed through the use of the muscle conditional CaMKIV gene knockout model.
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